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Figure 1. Structure of p19-siRNA Complex
Adapted from Ye et al., 2003.
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the annual aches and fevers from influenza virus show,The 447-52D Antibody: Hitting HIV-1
a highly successful one. The human immunodeficiencyWhere Its Armor Is Thickest virus type-1 (HIV-1) is a “master of disguise,” able to
alter itself at an evolutionary rate estimated to be a
million times faster than that of its human host. This
variation allows HIV-1 to stay several steps ahead ofThe problem of recognizing “non-self” is immensely
the immune system and is an essential component ofmore difficult when the “non-self” in question is hyper-
the virus’s ability to establish a persistent ultimately fatalvariable. In this issue of Structure, Stanfield et al.
infection.(2004) reveal the atomic-level basis for broad recogni-
If variation is armor, then the site where HIV-1’s armortion of a hypervariable loop of HIV-1.
is thickest is arguably the hypervariable V3 loop. This
loop, on the exterior gp120 envelope glycoprotein, is aAntigenic variation is a dominant mechanism of viral
escape from the immune system (Sharp, 2002) and, as site of extraordinary sequence variation in the HIV-1
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Clade B strains, which are currently the dominant type penetrating into the canyon allows broader recognition
(Smith et al., 1996). The same is true with HIV-1, withinfecting Europe and North America. But within the V3
hypervariability is a conserved stretch of four amino the b12 antibody reaching in with a long extended CDR
H3 loop to bind at the conserved CD4 binding heart ofacids—GPGR or GPGQ—at the loop tip. This tip conser-
vation is related to the function of the V3 loop in binding gp120 (Saphire et al., 2001). But now we have been
shown another way, by hitting the variation head on.to the HIV-1 coreceptor. So, although most antibodies
that recognize the V3 loop are type specific and easily Whether the particular mode of 447-52D recognition
will prove useful in vaccine development will depend onevaded by the virus, a tiny island of conservation exists
as a fracture in HIV-1’s variational armor. how efficiently antibodies like it can be elicited. Such
development will be aided by knowing the structuralZolla-Pazner and colleagues have investigated this
fracture and were able to isolate a number of antibodies, rationale for how broad recognition of the hypervariable
V3 loop can occur. Already one consequence of thiswhich were much less type specific than most V3 loop
antibodies. Their best, the 447-52D antibody from an understanding is that it generates an explanation for
why some strains resist 447-52D neutralization despiteHIV-1 infected individual (Gorny et al., 1992), was able
to neutralize virtually all laboratory-adapted strains of containing the GPxR motif: in resistant strains, quater-
nary interactions within the viral spike oppose the loopHIV-1 containing a GPxR motif and about 50% of Clade
B primary isolates. Its binding was also independent of conformation required for 447-52D binding, an exten-
sion of the conformational masking mechanism of viralcoreceptor usage, with 447-52D able to neutralize both
evasion (Kwong et al., 2002), which hinders anti-HIV-1CXCR4 and CCR5 coreceptor-using strains of HIV-1. In
receptor binding site antibodies. Perhaps binding toorder to understand the atomic-level basis for this broad
cell-surface CD4 will release these conformational con-recognition, the Zolla-Pazner group teamed up with
straints, as with the CD4i-class of anti-HIV-1 antibodiesStanfield, Wilson, and colleagues, who had already
(Labrijn et al., 2003), allowing an antigen binding frag-shown through half a dozen antibody:V3 epitope struc-
ment of 447-52D to neutralize more broadly.tures that the V3 loop was not only variable in sequence
The specific binding of sequence-variable proteinbut perhaps also in conformation (Ghiara et al., 1994;
segments forms a central problem in both cellular andStanfield et al., 1999).
humoral immune recognition. It will be fascinating toThe X-ray structure of 447-52D in complex with a V3
see whether the recognition of the gp120 V3 loop byloop peptide shows a 3-stranded mixed  sheet anti-
447-52D mimics the functional recognition of this loopbody:V3 loop interface (Stanfield et al., 2004). An extended
by coreceptor. How many ways are there to generateantibody heavy chain third complementary determining
conserved recognition of a highly divergent sequence?loop (CDR H3) forms two antiparallel strands, and the
No doubt, the team of Stanfield and colleagues will con-V3 loop itself forms a third parallel strand. Comparison
tinue to illuminate this central problem of immunologicalof the recognition by this antibody with previously deter-
recognition.mined structures of type-specific recognition demon-
strates furthermore that it is not the conformation of the
V3 loop in the antibody recognition that is unique but Peter D. Kwong
the mode of antibody recognition. Although the size of Vaccine Research Center
the surface of interaction between the V3 loop and 447- National Institutes of Health
52D was typical of antibodies, the specific types of inter- Bethesda, Maryland 20892
action were not. Most antibodies recognize proteins by
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